Medicine & Life Sciences
Prostatic Neoplasms
100%
Prostatectomy
42%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
32%
Androgens
18%
Finland
17%
Prostate
15%
Hypoglycemic Agents
14%
Cohort Studies
13%
Survival
11%
Cholesterol
11%
Neoplasms
11%
Atorvastatin
11%
Early Detection of Cancer
10%
Prostate-Specific Antigen
10%
Population
10%
Mortality
10%
Pharmaceutical Preparations
9%
Randomized Controlled Trials
8%
Erectile Dysfunction
8%
Castration
8%
Metformin
7%
Anti-Inflammatory Agents
7%
Drug Users
7%
Precision Medicine
7%
Antihypertensive Agents
7%
Recurrence
6%
Incidence
6%
Breast Neoplasms
6%
Registries
6%
Visual Analog Scale
6%
menthyl 3-(2-pyridylsulfinyl)acrylate
6%
Urinary Incontinence
6%
Adaptive Clinical Trials
5%
Phenomics
5%
Therapeutics
5%
MicroRNAs
5%
Fitness Trackers
5%
alfuzosin
5%
Case-Control Studies
5%
Simvastatin
5%
5-alpha Reductase Inhibitors
5%
oxidized low density lipoprotein
5%
Serum
5%
Aspirin
5%